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Abstract
The relevance of zinc for proper functioning of the entire immune system is already well
documented. However, the identification of individuals who really need zinc supplementation is still
debated in view of the fact that excessive zinc may also be toxic. The risk of developing zinc
deficiency in people from industrialized countries is relatively low, except for elderly subjects
where zinc intake may be suboptimal and inflammation is chronic. Thus, the role of zinc on the
immune system and on the health of European elderly people is becoming of paramount
importance, considering also that the elderly population is rapidly increasing. In particular, the
factors contributing to and the biochemical markers of zinc deficiency in the elderly are still remain
to be established. Epidemiological, functional, and genetic studies aimed at formulating a rationale
for the promotion of healthy ageing through zinc supplementation was the subject of an
International Conference held in Madrid from 11–13 February 2006 (3rd ZincAge Meeting) at the
CNIO Institute (local organizer: Maria Blasco, partner of ZincAge)
Introduction
ZincAge [1] is a specific targeted research project (STREP)
funded by the European Union in the 6th Framework Pro-
gram (FP6). It involves epidemiological studies on the
influence of diet and lifestyle on healthy ageing, aimed at
preventing adult degenerative disease, particularly focus-
ing on cardiovascular diseases and also addressing malnu-
trition of the elderly. The 3rd ZincAge meeting brought
together biochemical, genetic and lifestyle implications
for healthy ageing in the context of nutritional impact of
zinc.
It is quite clear that antioxidant and micronutrients in the
diet, such as zinc, influence the development and func-
tion of immune cells, the activity of stress-related proteins
and antioxidant enzymes and help to maintain genomic
integrity and stability. All these functions occur through
the action of proteins involved in the regulation of zinc
homeostasis, such as metallothioneins (MT), which bind
zinc with high affinity but, at the same time, release free
zinc ions in response to oxidative/nitrosative stress to
modulate the expression of zinc-dependent genes and to
activate antioxidant enzymes and impact immune
response. Thus, the role of zinc is mainly to transduce oxi-
dative stress and other signals converging at the produc-
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tion of nitric oxide into an specific intracellular response,
suggesting an intriguing task of "signal transducer", simi-
lar to that found for calcium in the past. However, many
aspects of this model are still unexplored, because the
intracellular mechanisms involved in the regulation zinc
homeostasis have been poorly studied in ageing.
It is known is that during ageing, the intake of zinc
decreases, thus contributing to cause frailty, general disa-
bility and increased incidence of age-related degenerative
diseases (cancer, infections and atherosclerosis). This situ-
ation may be better or worse in different European coun-
tries, taking into account the large differences in dietary
habits between southern and northern areas. One of the
aim of the ZincAge project is therefore to investigate how
different dietary habits and intrinsic factors (genetic back-
ground) contribute to the risk of developing zinc defi-
ciency in different European countries [1]. Considering all
these aspects, the meeting was divided into 5 sessions.
Session 1) Zinc, genetic background and brain
Chronic non-specific inflammation and immunopathol-
ogy, which are thought to be a major problem in ageing,
contribute significantly to the decline of the zinc status
possibly aggravated by an unfavourable genetic back-
ground concerning genes involved in the inflammatory
response (such as TNF-alpha and IL-6) and in the mainte-
nance of zinc homeostasis, such as metallothioneins
(MT). This means that in order to perform an appropriate
supplementation with zinc in the elderly, it is necessary to
consider zinc status, dietary habits and the individual
genetic background. This last point may be crucial also in
order to identify subjects that are at higher risk of develop-
ing zinc deficiency in ageing. In such subjects, there is the
potential for a preventive intervention with zinc supple-
mentation as suggested by Eugenio Mocchegiani
(INRCA, Ancona, Italy) (Coordinator of the project) [2]
who reported on the existence of differences in zinc status,
measured by total plasma zinc, available intracellular and
plasma zinc and MT, in elderly individuals recruited in
different European countries (Italy, France, Germany,
Poland and Greece). This was found to be related to dif-
ferent dietary habits and to the presence of particular pol-
ymorphisms of IL-6 and MT genes, thus confirming that
the rationale for zinc supplementation should take these
factors into account. This issue was further extended in the
"young scientists session" of the Meeting by Catia Cipri-
ano (INRCA, Ancona, Italy), who showed the relevance
of MT functional polymorphisms for successful ageing,
and by Marco Malavolta (INRCA, Ancona, Italy) who
discussed the role of genetic factors in determining zinc
dyshomeostasis in ageing with an emphasis on a flow
cytometry-based assay to detect the NO-induced release of
zinc from MT.
Since the elderly population is rapidly increasing, and the
prevalence of overweight and obesity in elderly popula-
tions ranges widely upon geographical location and study
design, George Dedoussis (Harokopio University, Ath-
ens, Greece) [3] reported the health status, blood and
anthropometrical indices from 249 old Greek subjects
(including nonagenarian) in relation to plasma zinc and
dietary habits. Blood analysis confirmed the good health
status of the elderly population recruited except for the
high prevalence of obesity and hypercholesterolemia,
which are in accordance with similar studies conducted in
the elderly Greek populations [4].
A multi-disciplinary approach was used in the Zincage
project in order to evaluate the relationship between zinc,
psychosocial conditions and life-style in old healthy sub-
jects. Fiorella Marcellini (INRCA, Ancona, Italy) [5] used
a series of tests and questionnaires chosen with special
regard to elderly people, including a life-style Question-
naire and a Food Frequency Questionnaire designed for
the needs of Zincage in collaboration with George
Dedoussis, the Mini Mental State Examination (MMSE),
the Geriatric Depression Scale (GDS 15 items) and the
Perceive Stress Scale (PSS). The results were an important
outcome to evaluate the psychological differences among
European elderly subjects (including nonagenarians) in
relation with their zinc status. All psychological variables
in the whole sample were related to physical zinc meas-
urement. Among European countries, Greek elderly peo-
ple, who were characterized by the lowest levels of plasma
zinc, displayed also a significantly higher score both for
PSS and GDS and a more marked age-dependent decline
of MMSE when compared to other countries. In contrast,
the old French population, which was characterized by
the highest levels of plasma zinc, also had the lowest GDS
and PSS scores and the highest score of MMSE compared
with the other countries. A specific insight on lifestyle and
psychological aspects of the Italian elderly, that confirmed
the general trend shown in the whole sample, was further
delineated in the "young scientists session" by Cinzia
Giuli and Roberta Papa (INRCA, Ancona, Italy). Even if
these results suggested that the zinc status is somehow
positively associated with psychological variables, the
rationale for promoting zinc supplementation in the eld-
erly must be considered in the context of the possible neu-
rotoxic effects of Zn2+[6]. Addressing the injurious role of
zinc in neurological disease, Stefano Sensi (University G.
D'Annunzio, Chieti, Italy) showed how excessive influx
and/or mobilization of free zinc ions in neurons can pro-
mote the neuronal injury observed in cerebral ischemia,
epilepsy, and brain trauma. The mechanisms by which
zinc exerts its neurotoxicity include mitochondrial and
extra-mitochondrial production of reactive oxygen species
and disruption of metabolic enzyme activity, ultimately
leading to activation of apoptotic and/or necrotic proc-Immunity & Ageing 2006, 3:6 http://www.immunityageing.com/content/3/1/6
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esses. Interestingly, in addition to acute neuronal injury,
disturbances of zinc metabolism has also been demon-
strated to play a role in the pathogenesis of Alzheimer's
disease (AD) as the zinc cation acts as a potent trigger for
beta-amyloid aggregation and plaque formation. Zinc is
indeed found in high concentrations in mature amyloid
plaques and its chelation has been found to effectively re-
solubilize beta-amyloid from human postmortem AD
plaques. These data suggest that the use of zinc supple-
ments in elderly people should be considered only after a
careful evaluation of the zinc status of the subjects as well
as their genetic background particularly those genes
related to the expression and mutation of proteins
involved in Zn2+ homeostasis.
Session 2) Zinc and oxidative stress
In view of the fact that the release of zinc from MT repre-
sents an intracellular response to stress, biochemical mod-
ification of stress-related proteins might represent a useful
target to influence zinc homeostasis and related mecha-
nisms in ageing. Alexander Bürkle (University of Kon-
stanz, Germany) [7,8] established a FACS-based
immunoassay for the quantitative assessment for
poly(ADP-ribose) polymerase 1, an abundant nuclear
enzyme that binds via its zinc finger motifs to DNA with
single or double strand breaks. The maximal level of
PARP-1 activity is strongly correlated with life span of
mammalian species, whereas within a given species max-
imal PARP-1 activity tends to decrease with donor age.
Using this FACS-based immunoassay this group is
addressing the possible link between PARP-1 activity and
zinc status in humans. This aspect was extended by And-
rea Kunzmann (University of Konstanz, Germany) who
showed how cellular poly(ADP-ribosyl)ation capacity is
modulated by in vitro zinc supplementation in PBMC.
As cellular poly(ADP-ribosyl)ation capacity is related to
DNA damage and repair, it is relevant to study altogether
these aspects in order to understand the impact on the
functional status of the DNA repair mechanisms. With
this aim, in the "young scientists session", María Moreno-
Villanueva  (University of Konstanz, Germany)
addressed the influence of in vitro zinc on the repair capac-
ity of Jurkat cells and human PBMC using an automated
version of the fluorescence-detected alkali DNA unwind-
ing (FADU) assay for the analysis of cellular DNA repair
capacity. It appears that DNA repair capacity of PBMCs
even from young, healthy donors can be increased by the
simple addition of zinc in the physiological range. The
results were very similar to the increase in poly(ADP-ribo-
syl)ation capacity.
A common cause of DNA damage and triggering of repair
is the production of reactive oxygen species (ROS).
Jolanta Jajte (Medical University of Lodz, Poland) [9] is
assessing, by FACS and spectrofluorimetric method anal-
ysis, the modification of various cell components by ROS
which are implicated in ageing and in numerous human
diseases, such as cardiovascular disease, neurodegenera-
tive processes and cancer. She analyzed the generation of
ROS species in lymphocyte of healthy elderly subjects and
atherosclerotic old patients and found a significant corre-
lation between ROS generation and pathological changes
in old atherosclerotic patients.
Protection against enhanced exposure to ROS, as it occurs
in ageing, is mainly achieved by the gene expression of
stress-related proteins such as Clusterin/Apoliprotein J
(ApoJ). Efstathios S. Gonos (National Hellenic Research
Foundation, Athens, Greece) approached ageing and
longevity at the molecular level by studying the functions
and the relevance for successful ageing of ApoJ. This has
been recently identified as a novel survival factor [10]
based on its cytoprotective function, which was demon-
strated also by the sensitization of cell towards cytotoxic-
ity resulting from suppression of ApoJ expression.
In the "young scientists session" Ioannis P. Trougakos
(National Hellenic Research Foundation, Athens,
Greece) further showed that ApoJ expression can be mod-
ulated by zinc and that ApoJ levels in the plasma may be
used as a biochemical marker of zinc status.
Besides work on Apo J, the Gonos group set up an overall
molecular and biochemical approach to understand pro-
teasome functions in replicative senescence and cell sur-
vival, thus creating the basis for a possible investigation
on the role of zinc in proteasome functions.
The accumulation of oxidatively modified proteins may
represent an important hallmark of cellular ageing and
pathology that is associated with oxidative/nitrosative
stress. Marco Colasanti and Giovanni Musci (University
of Rome 3, Rome, Italy) [11] determined the age-related
changes occurring in MT and other zinc-dependent pro-
teins, such as Specific Protein-1 (SP-1), showing for the
first time that these proteins may be glutathionylated and
that their important role in the adaptive cellular response
to oxidative and nitrosative insults during ageing might
thereby be lost. In addition, this group found that MT may
also be differently glutathionylated upon ageing suggest-
ing the presence of specific changes involving different MT
isoforms.
Given the possibility that MT may become dysfunctional
during ageing, corresponding changes in the activity of
other zinc dependent enzymes might be found. Methio-
nine sulfoxide reductase B (MsrB) is a zinc dependent pro-
tein-repairing enzymes that together with MsrA has the
specific function of removing oxidatively-damagedImmunity & Ageing 2006, 3:6 http://www.immunityageing.com/content/3/1/6
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methionine residues. Bertrand Friguet (University
Denis-Diderot, Paris, France) [12,13] has developed
enzymatic and immunochemical assay using cellular
extracts from cells isolated from young and middle-aged
individuals to monitor proteasome and methionine sul-
foxide reductase activity and/or expression. The goal is to
establish, within the ZincAge project, whether there is evi-
dence for a correlation of the monitored parameters with
age, gender and other factors relevant to zinc and oxida-
tive stress.
Preliminary results, shown by Filipe Cabreiro (University
Denis-Diderot, Paris, France), during the "young scien-
tists session", on the effect of zinc on MOLT-4 cells over-
expressing MsrA or MsrB demonstrate that increasing zinc
concentration up to 50–75 µM lead to an increase in cells
viability. Surprisingly, the addition of zinc seems also to
decrease MsrA and MsrB activity, whereas chelating rea-
gents have no effect on the metal content and on the activ-
ity of MsrB, thus suggesting a tight binding of the metal on
the active site of this protein.
Molecular chaperones or stress proteins maintain the cor-
rect conformational homeostasis of proteins, protecting
them against a number of stresses [14]. Proper function of
these stress proteins is required for longevity [15]. Indeed,
a hallmark of ageing is represented by an increase of
aggregated and oxidized proteins. However, little is
known about the causal relationship between protein
misfolding, oxidative stress and chaperone induction.
Moreover, the role of zinc as an immunomodulator and
as an inducer of the stress response is not clear in this
process. Csaba Sőti (Semmelweis University, Budapest,
Hungary) [14] used the T-lymphocytic Jurkart cell line to
analyze the relationship between protein misfolding,
aggregation and chaperone induction. He found that, in
contrast to the already known non-specific induction of
heat shock proteins (Hsp70, Hsp90) caused by heat
shock, oxidative stress increased expression of only certain
Hsp proteins (Hsp90). Moreover, mild oxidative stress
did not induce bulk protein denaturation and stress
responses raising the question of how oxidative modifica-
tion is able to induce chaperone expression. The mobili-
zation of free zinc ions in response to oxidative stress
might be involved in this phenomenon. Regarding the
role of in vitro zinc on the modulation of chaperone
expression in Jurkat cells, Soti showed that 12 µM was the
optimal doses to induce chaperone expression and that
higher zinc concentrations counteracted the heath shock
and oxidative stress mediated induction of chaperones.
Therefore, inhibition of chaperone expression might be
one of the mechanisms involved in the toxicity of exces-
sive amount of zinc.
Together with intracellular antioxidant and stress
response proteins, an important role during ageing is
assigned to the proteins involved in the extracellular anti-
oxidant response. Patrizia Mecocci (University of Peru-
gia, Italy) [16] measured the activities of a large spectrum
of enzymatic antioxidants, such as plasma glutathione
peroxidase (GPx), plasma catalase (Cat), plasma and
erythrocyte superoxide dismutase (pSOD and eSOD) in
subjects enrolled from different European geographical
areas, including old subjects, atherosclerotic patients,
nonagenarians, patients with infection and patients with
cancer. Higher activity of GPx and pSOD was found in old
subjects with atherosclerosis compared to old subjects
with infection and to nonagenarians. The activity of GPx,
Cat and pSOD did not differed with respect to gender,
whereas eSOD was present higher values in women. The
same enzyme displayed an age-associated increased activ-
ity, but the addition of zinc to erythrocytes from old
donors in vitro was able to influence eSOD activity only
slightly. Therefore, factors other than zinc, could be
involved in the age-related up-regulation of eSOD activity.
One of these factors may be the trace element copper
which, in addition to zinc, is necessary for the catalytic
activity of the enzyme. Therefore, further studies will be
also undertaken to clarify the influence of the zinc/copper
ratio on eSOD activity in elderly and nonagenarian sub-
jects.
Session 3) Zinc and genome stability
Dysfunctional telomeres trigger a stress response and pro-
vide molecular clues to the mechanisms linking growth
suppression, zinc homeostasis and dysfunctional telom-
eres in mammalian cells.
Maria Blasco (CNIO, Madrid, Spain) [17], studying the
effect of telomerase expression and telomere length on
stem cell behaviour, demonstrated that critical telomere
shortening has a negative impact on the proliferative
capacity of bone marrow and neural stem cell and that tel-
omere shortening in the absence of telomerase negatively
impacts on the mobilization of epidermal stem cells.
Using a microarray approach, Blasco showed also that
overexpression of the catalytic subunit of telomerase
(mTert), in primary murine cells, abrogates expression of
the growth-inhibiting genes of the TGF-beta pathway and
down-regulates some zinc-dependent transcription fac-
tors, such as Egr2, Klf4 and Zfp36. In contrast, the gene
Txnip, involved in the redox-recycling of MT sulphur lig-
ands, was found to be up-regulated by mTert overexpres-
sion. These results suggest that MT might also be involved
in the stress response mediated by dysfunctional telom-
eres.
Gene array technology was also applied by Dawn Maz-
zatti and Jonathan Powell (Unilever, Colworth, UnitedImmunity & Ageing 2006, 3:6 http://www.immunityageing.com/content/3/1/6
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Kingdom) [18] to investigate the regulation of gene
expression by zinc in vitro. Preliminary data indicate that
several zinc-dependent genes (mainly specific MT iso-
forms and zinc transporters) and functional pathways are
conserved between models, indicating their importance
in zinc-mediated regulation of gene expression. The trans-
lation of these data to in vivo zinc supplementation is cur-
rently in progress.
Genome stability is controlled by a complicated network
which involves many regulators. Zinc has been generally
reported as a positive regulator of genome stability
because it contributes to preventing DNA damage via
modulation of the zinc dependent stress-response genes.
Jolanta Jajte and Janusz Blasiak (Medical University of
Lodz, Poland) [9] found a significant correlation between
DNA damage and DNA repair activity in lymphocytes of
healthy elderly subjects and ill old atherosclerotic
patients. Considering that increased levels of DNA dam-
age is associated with the ageing process and that zinc sta-
tus decreases with age, the capability of in vitro zinc to
protect human PBMC from oxidative stress and DNA
damage was tested. In contrast to the general protective
effects shown in PBMC taken from young subjects, zinc
was found to differently affect DNA damage induced by
hydrogen peroxide in PBMC taken from old subjects.
Thus, not all elderly subjects may respond in the same way
to zinc supplementation perhaps due to a different genetic
background. Therefore, genetic screening targeted to pro-
inflammatory cytokines and MT genes might be the key to
understanding the different behaviour of cells taken from
elderly and identify old subjects who really need to be
supplemented with zinc.
Session 4) Zinc and signal triggering
Zinc plays an important role in cellular signalling and the
zinc finger motifs which characterize several transcription
factors are extraordinarily conserved among eukaryotic
cells.
Tamas Fulop (University of Sherbrooke, Canada) [19]
reviewed the multiple functions of zinc in biological sys-
tems, with an emphasis on the modulation of cytokine
signal transduction in immune cells. Zinc can also influ-
ence other transcription factors by affecting DNA binding
domain as well as their activation. Furthermore, zinc itself
can also activate signalling molecules like calcium, by
stimulating various pathways. Altogether these functions
can modulate T cells response, proliferation and survival
in response to pro-apoptotic signals. Thus, zinc deficiency
observed with ageing can play a significant role in T cell
activation changes and consequently in immunosenes-
cence.
Since it is very well known that immune responses decline
with ageing, Audrey Varin and Georges Herbein (Univer-
sity of Franche-Comté, Besancon, France) [20] studied
the signal transduction, focusing on the activation of STAT
pathway in T cells of elderly healthy subjects on exposure
to cytokines (IL-2 and IL-6) and zinc stimulation. They
found that with ageing there is an alteration in the Jak/
STAT activation in response to IL-2 and IL-6 activation.
Zinc supplementation in vitro slightly improved the age-
related decrease depending on the age groups tested and
the basal level of the Jak/STAT pathway activation.
Daniela Monti and Rita Ostan (University of Florence,
Italy) [21] analyzed the role of zinc in cell proliferation
and apoptosis affecting the development and integrity of
the immune system. They studied the impact of the sub-
stitution (Arg to Pro) in the p53 codon, which affects
apoptosis and cell cycle in an age-dependent manner.
They also investigated the relationship between apoptosis
and zinc treatment. They found that in arginine/arginine
carriers zinc is able to decrease early apoptosis and to
increase late apoptosis/necrosis. In contrast, no effect was
detected in proline/proline or proline/arginine carriers.
Furthermore, zinc treatment induces decreased S phase
commitment and concomitant increase of the cells in the
G2/M phase in old subjects treated with different concen-
trations of zinc. These results suggest that functional pol-
ymorphisms other than MT and cytokine genes may be
involved in the individual response to zinc supplementa-
tion. Thus, future efforts will also be directed towards the
evaluation of apoptosis and cell-cycle control in old sup-
plemented individuals in relationship to p53 polymor-
phisms.
Session 5) Zinc and immune mediators
Long term clonal cultures represent good models for stud-
ying the behaviour of T cells under chronic antigenic stress
and facilitate the in vitro testing of interventions in a lon-
gitudinal ageing system. Graham Pawelec (University of
Tübingen, Germany) [22] described the effect of zinc sup-
plementation on growth characteristics surface molecule
expression, cytokine production and heat shock protein
expression of human CD4+ T cell clones (TCC) derived
from young and old donors, including centenarians. The
results suggested that at least for T cells, the impact of zinc
over-supplementation may be limited to decreased cell
growth rates, perhaps due to increased apoptosis, but that
surviving cells are unlikely to be functionally compro-
mised. Of particular interest, Sven Koch (University of
Tübingen, Germany) [23] from the same Pawelec group
has investigated the CMV repertorie in the elderly using
MHC/peptide multimers in different European popula-
tions, including Zincage donors (62–90 yrs. old). He
found that T cells specific for CMV specific, such as
CD8+CD45RA-CCR7-CD28-CD57+ terminally differenti-Immunity & Ageing 2006, 3:6 http://www.immunityageing.com/content/3/1/6
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ated phenotype cells, express high levels of the inhibitory
killer lectin-like receptor KLRG1. However, high KLRG1
expression and CMV IgG titre did not correlate signifi-
cantly with increasing ageing suggesting that KLRG1 may
be a valuable biomarker of immunosenescence. There-
fore, the deletion of CMV-specific KLRG1/CD57-double
positive dysfunctional CMV-specific cells might be of ben-
efit in at-risk elderly. The impact of zinc in this CD8+ cell
populations will be assessed in old zinc supplemented
individuals.
The role of the thymus is vital for orchestration of T cell
development and maturation.Richard Aspinal and
Wayne Mitchell (Imperial College London, UK) [24]
evaluating the role played by zinc in maintaining thymic
output in healthy elderly individuals used FACS analysis
and real time PCR technology. They carried out experi-
ments on thymic output in healthy individuals aged
between 60–90 years, prior to supplementation with zinc.
They analyzed 300 individuals for the total T cell numbers
(CD3) and recent thymic emigrants (TRECs). The results
indicate that TREC levels are stable between countries but
females have slightly higher values compared to male.
Further efforts will be addressed to understand the effects
of zinc supplementation on thymic output in elderly.
Cellular components of both the adaptive and innate
immune system produce different cytokines and chemok-
ines which modulate effector function during the
immune response. Accordingly, Erminia Mariani (Istituti
Ortopedici Rizzoli, Bologna, Italy) [25,26] evaluated the
concentration of three CC type chemokines (MCP-1, MIP-
1alpha and RANTES), a CXC type chemokine (IL-8) and
two pro-inflammatory cytokines (IL-6 and TNF-alpha) in
human plasma samples obtained from subjects of various
age and from the different European countries. The circu-
lating levels of each soluble factor, analysed in pooled
samples from old healthy subjects were significantly cor-
related with each other and with plasma zinc, suggesting
that being high or low producers, at least for these factors,
is a distinct intrinsic feature of each individual and may be
related to the individual regulation of zinc homeostasis.
There was also a general trend to increases in all these sol-
uble factors under pathological conditions, including
obesity, suggesting an inflammatory status in pathology
independently of the age of the subjects.
Since experimental human zinc deficiency is known to
decrease Th1 but not Th2 immune response, Lothar Rink
(Aachen University, Germany) [27,28] investigated the
effect of a preliminary supplementation trial with zinc in
Germany on the Th1/Th2 balance and on T cell activation.
Preliminary results showed that the number of CCR4
(TH2) and CCR5 (TH1)-positive T cells did not change
significantly after zinc treatment, whereas the number of
activated T cells (CD4+/CD25+) was significantly
decreased. Additionally, a method to quantify zinc
importer (hZIP), zinc exporter (ZnT) and intracellular free
zinc by flow cytometry was established. The altered
expression profile of these transporters and their homeos-
tasis has a direct influence on the cells. Down regulation
of hZIP seems to be a prerequisite for immortalisation,
whereas up-regulation of hZIP favoured apoptosis in T
cell. Despite the possibility that the effect of zinc in cells
from elderly subjects might sometimes be to induce and
sometimes to prevent apoptosis or DNA damage, depend-
ing on the doses and individual characteristics, there is a
general agreement that zinc supplementation with physi-
ological doses is generally beneficial for the individuals.
One explanation for this potential paradox might be
found in the hormetic theory. Hormesis in ageing, as dis-
cussed in details by Suresh Rattan (University of Aarhus,
Denmark) [29], is characterized by the beneficial effect
that results from the cellular response to mild stress. His
studies have shown that repeated mild heat stress (RMHS)
has anti-ageing effect on growth and various other cellular
and biochemical characteristics of normal human skin
fibroblasts undergoing ageing in vitro. RMHS has also
been tested in combination with potential hormetic mol-
ecules, such as curcumin, on ageing and longevity of
human cells in culture.
In contrast to mild stress, the life long antigenic burden
leads to a condition of chronic inflammation with
increased lymphocyte activation and pro-inflammatory
cytokine production. In this context, Calogero Caruso
(University of Palermo, Italy) [22,30] has studied zinc
availability in old subjects with coronary artery disease,
healthy controls and centenarians with respect to a pro-
inflammatory or anti-inflammatory genotype. In age-
related diseases zinc seems to influence, through bio-
molecular pathways, inflammatory mediators that, in
turn, influence zinc availability. The results confirmed
that the zinc sequestering proteins, such as MT, at least in
ageing show a correlation with inflammation.
This last aspect may be also relevant in non-pathological
conditions, taking into account that chronic antigenic
load is the major driving force of immunosenescence
Finally, Rafael Solana (University of Cordoba, Spain)
[22,31] showed that the T cell subpopulation
CD8+CD28null, characterized by high NK associated
receptor expression and effector memory (EM) pheno-
type, is expanded in elderly donors when compared to
young and that this expansion is associated with CMV
seropositivity and to increased risk of death. It has been
described that CMV is major inducer of oligoclonal
expansion in ageing. Solana found a significant expan-
sion both in young controls and healthy elderly donorsImmunity & Ageing 2006, 3:6 http://www.immunityageing.com/content/3/1/6
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after antigenic stimulation. This introduces the idea that
the expansion of a subset (EM2) of CD8+ T cells in the
elderly is due to a biased differentiation after chronic stim-
ulation of the immune system somehow driven by persist-
ent antigens such CMV. The possibility that the
individual's zinc status might help to keep under the
undesired effects of persistent viruses like CMV under con-
trol, will also be investigated during the ZincAge Project.
Conclusion
Improving our knowledge of the many factors related to
the control of zinc homeostasis and immune efficiency in
ageing is necessary in order to develop frailty prevention
programmes based on zinc supplementation. In fact, it is
clear that zinc is of extraordinary and diverse importance
in human biology and nutrition but, especially in ageing,
zinc research is still in a relatively immature stage of devel-
opment. New knowledge on the function of metal-
lothioneins, zinc transporters and on the effect of the
genetic background has been acquired or is emerging,
based on innovative methods and technologies for the
assay of zinc ion availability and the related activity of
zinc-dependent enzymes. The answer to many scientific
questions regarding the characterization of the benefits/
risks of zinc supplementation in the elderly and of zinc
responsive biological systems, including oxidative stress
and host defence against infection, will hopefully be
attained after extensive discussion of the results at the end
of the Zincage Project, with a particular focus on the dif-
ferent dietary habits in various European countries.
Indeed, different diets associated with zinc status may be
recommended at the end of the Project in order to main-
tain zinc homeostasis and consequently to maintain good
health status and achieve longevity.
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